Back
Cyclerion Therapeutics 10K Form
Buy
55
CYCN
Cyclerion Therapeutics
Last Price:
3.40
Seasonality Move:
10.81%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CYCN News And Ratings
See the #1 stock for the next 7 days that we like better than CYCN
CYCN Financial Statistics
Sales & Book Value
| Annual Sales: | $297K |
|---|---|
| Cash Flow: | $-1.72M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.24 |
| Price / Book: | 1.13 |
Profitability
| EPS (TTM): | -2.14000 |
|---|---|
| Net Income (TTM): | $-5.28M |
| Gross Margin: | -- |
| Return on Equity: | -51.71% |
| Return on Assets: | -44.82% |
Cyclerion Therapeutics Earnings Forecast
Key Cyclerion Therapeutics Financial Ratios
- The Interest Expense is -0.04% of Operating Income.
- Per Share Earnings over the last 7 years have been positive in 4 years.
Cyclerion Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CYCN |
| Website: | cyclerion.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 5.07 |
| Quick Ratio: | 4.17 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CYCN Technical Analysis vs Fundamental Analysis
Buy
55
Cyclerion Therapeutics (CYCN)
is a Buy
Is Cyclerion Therapeutics a Buy or a Sell?
-
Cyclerion Therapeutics stock is rated a Buy
The current Cyclerion Therapeutics [CYCN] share price is $3.43. The Score for CYCN is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.